$ROL

Rollins (ROL) Stock Faces High P/E As Net Margin Slightly Undercuts Bullish Narratives

Simply Wall St reports Rollins (NYSE:ROL) posted Q2 2026 revenue of $1.1B and basic EPS of $0.30. Trailing twelve-month revenue was $3.9B with EPS of $1.10 and net income of $531.7M, implying a 13.6% net margin. The stock trades at a 35.7x trailing P/E versus 19.6x industry, with DCF fair value $47.62 vs $39.44 price and an analyst target of $56.35.

Original reporting
Published Jul 24, 2026, 12:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 4:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rollins (ROL) Stock Faces High P/E As Net Margin Slightly Undercuts Bullish Narratives — source image
Decision brief

The 30-second read

$ROLNeutralLow
01

Why it matters

The trading takeaway is a valuation and earnings-quality tension: premium P/E (35.7x) versus only modest margin movement (13.7% to 13.6%) and lumpier quarterly EPS.

02

Market read

Useful for positioning around whether the market is overpaying for Rollins’ current earnings power, but it does not introduce a new catalyst beyond the cited Q2 metrics.

03

What to watch

The article does not break out segment trends, cash flow quality, or specific cost drivers behind the regulatory/technology cost narrative, which could explain the small margin slip.

Relevance 4/10Novelty 4/10Timing: after-hours/ongoing valuation debate following Q2 2026 results reference points

Background

Simply Wall St summarizes Rollins’ Q2 2026 financial reference points and contrasts bullish compounding narratives with valuation and margin drift.

Company-level read

Ticker impact

$ROLNeutralMedium confidence
Context

Rollins reports Q2 2026 revenue of $1.1B and EPS of $0.30, with trailing net margin at 13.6% and valuation at 35.7x P/E.

Expected impact

Near-term price reaction risk is modest, with the main effect being a valuation re-rating rather than a clear catalyst for upside or downside.

Evidence & confidence

No new guidance or event beyond reported Q2 metrics is disclosed; the piece is primarily a valuation and narrative check using provided financial datapoints.

Market effects

If the margin profile is harder to expand, it can reinforce a more cautious stance on commercial services peers trading at premium multiples.

Primarily US-focused read-through given the NYSE listing and US industry multiple comparisons.

Limited, as the article does not introduce international regulatory or macro shocks beyond general cost pressure narratives.

Counterpoint

The mid-teens trailing net margin (13.6%) and higher trailing net income ($531.7M) suggest profitability remains intact despite small margin drift.

Key entities

  • Rollins

    NYSE-listed pest and wildlife control services provider; subject of the article’s earnings, margin, and valuation discussion.

Related articles

$ROLMedAI 8/10

Rollins shares drop 9.3% after Q2 earnings

Rollins, Inc. reported Q2 2026 operating margin of 18.7%, down 110 bps year over year, and operating cash flow of $173 million, down 1.5%. CEO Jerry Gahlhoff said results missed expectations due to a weaker lead environment and fewer customers using digital pest-control searches. Rollins shares fell about 9.27%.

$ROLMed

JPMorgan cuts Rollins to Neutral on demand uncertainty, slashes price target

JPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70, citing uncertainty from weakening residential demand and a slower margin recovery. It lowered fiscal 2026/2027 revenue growth forecasts to 8.7% and 8.4%, adjusted EBITDA margins to 21.9% and 22.2%, and adjusted EPS to $1.17 and $1.26. The move follows a weaker Q2 with declining lead volumes.

$ROLMedAI 8/10

Rollins Analysts Cut Their Forecasts After Downbeat Q2 Earnings - Rollins (NYSE:ROL)

Rollins Inc (NYSE:ROL) reported Q2 results after the close. Earnings were 32 cents per share versus a 34-cent consensus, and sales were $1.079 billion versus $1.092 billion expected. Shares fell 1.7% to $38.78 premarket. After the report, JP Morgan cut its target to $45 from $70 and downgraded to Neutral, while Wells Fargo cut to $32 from $46 and downgraded to Underweight.

$ROLMed

Wells Fargo says ditch this pest control stock as demand continues to soften

Wells Fargo downgraded Rollins (ROL) to underweight from equal weight and cut its price target to $32 from $46, citing softer residential pest-control demand. The bank cited headwinds including weather, potential impacts from LLMs, more aggressive competition, and more price-sensitive consumers. Rollins reported 5.7% organic growth, missed Q2 estimates, and lowered FY2026 guidance to about 6%.